Advanced analysis of cells and tissues to improve cancer understanding and treatment
Official title: Cell and Tissue Analysis Core
Funded at University of Oklahoma Hlth Sciences Ctr · NIH-10936137 · Data updated 2026-11-12
This study is all about using new technologies to better understand cancer and improve treatments, so that patients can benefit from more effective ways to diagnose and fight the disease.
Quick facts
| Grant type | P30 center grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Oklahoma Hlth Sciences Ctr NIH-funded |
| Lab location | 1 site (Oklahoma City, United States) |
| Project start | August 10, 2024 |
| Project end | June 30, 2029 |
| Funding year | 2024 |
| Award (this year) | $317,460 |
| NIH project number | 1P30GM154635-01 |
| Project ID | NIH-10936137 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for participation or benefit from this research are individuals diagnosed with various types of cancer.
✕Less likely to help
Patients with non-cancerous conditions or those not involved in cancer research may not receive any benefit from this research.
What this research studies
The Cell and Tissue Analysis Core focuses on developing and utilizing advanced technologies for the analysis of molecular, cellular, and tissue samples related to cancer. This core facility collaborates with researchers to optimize experimental designs and provides comprehensive services such as tissue microarray construction, immunohistochemical staining, and in situ hybridization techniques. By integrating these advanced methodologies, the core aims to enhance the understanding of cancer biology and improve therapeutic strategies. Patients may benefit from the insights gained through this research, which could lead to more effective cancer diagnostics and treatments.
Why it matters
Potential benefit: If successful, this research could lead to improved cancer diagnostics and more effective treatment options for patients.
How similar studies have gone: Previous research utilizing advanced cellular and tissue analysis techniques has shown promise in enhancing cancer understanding and treatment outcomes.
Where this research is happening
-
University of Oklahoma Hlth Sciences Ctr
Oklahoma City, United States Active
Researchers
- Principal investigator: Jayaraman, Muralidharan — University of Oklahoma Hlth Sciences Ctr
- Study coordinator: Jayaraman, Muralidharan
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.